KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 107 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 12.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $177,000 | +216.1% | 2,356 | +219.2% | 0.00% | – |
| Q2 2015 | $56,000 | +154.5% | 738 | +65.1% | 0.00% | – |
| Q1 2015 | $22,000 | +37.5% | 447 | -0.2% | 0.00% | – |
| Q4 2014 | $16,000 | 0.0% | 448 | -9.3% | 0.00% | – |
| Q3 2014 | $16,000 | -11.1% | 494 | +2.7% | 0.00% | – |
| Q2 2014 | $18,000 | -5.3% | 481 | 0.0% | 0.00% | – |
| Q1 2014 | $19,000 | +5.6% | 481 | +1.1% | 0.00% | – |
| Q4 2013 | $18,000 | -69.5% | 476 | -63.0% | 0.00% | -100.0% |
| Q3 2013 | $59,000 | +210.5% | 1,288 | +87.5% | 0.00% | – |
| Q2 2013 | $19,000 | – | 687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 48,087 | $1,668,000 | 4.13% |
| Versant Venture Management, LLC | 70,376 | $2,440,640,000 | 2.33% |
| Palo Alto Investors LP | 1,121,884 | $38,907,000 | 2.28% |
| Aureus Asset Management, LLC | 124,087 | $4,303,000 | 1.05% |
| PFM Health Sciences, LP | 1,085,315 | $37,639,000 | 0.88% |
| HARBOURVEST PARTNERS LLC | 39,318 | $1,364,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,119,425,000 | 0.52% |
| Partner Investment Management, L.P. | 24,456 | $848,000 | 0.35% |
| Old West Investment Management, LLC | 15,162 | $525,000 | 0.32% |
| Polar Capital LLP | 405,544 | $14,063,000 | 0.27% |